LED Medical Diagnostics Inc.

TSX VENTURE : LMD
OTCQX : LEDIF
FRANKFURT : LME


LED Medical Diagnostics Inc.

December 03, 2013 09:25 ET

LED Medical Announces US Distribution Agreement with Burkhart Dental Supply

BURNABY, BRITISH COLUMBIA--(Marketwired - Dec. 3, 2013) - LED Medical Diagnostics Inc. ("LED Medical, the Company") (TSX VENTURE:LMD) (OTCQX:LEDIF) (FRANKFURT:LME) is pleased to announce that its wholly‐owned subsidiary, LED Dental Inc., has entered into a non‐exclusive partnership with Burkhart Dental Supply ("Burkhart") for the distribution of the company's VELscope® Vx Enhanced Oral Assessment System and product line within the United States market.

"We are pleased to partner with Burkhart, one of the most respected dental supply companies in the United States," stated Dr. David Gane, CEO for LED Medical. "For over 125 years Burkhart has been committed to serving dental practitioners with quality equipment and supplies, comprehensive product training, as well as strong after‐sales support. Their strong market presence and deep network is ideally suited to our expansion strategy for the VELscope® Vx product line in the United States."

"We are pleased to carry the VELscope Vx product line for our US network," states Lori Burkhart Isbell, President of Burkhart. "The VELscope® Vx sets the standard for tissue fluorescence visualization and is a market leading adjunctive oral mucosal examination tool that is in demand with our client base. It has also proven to be highly effective for the early detection of oral cancer and pre‐cancers, and we support it as an important, potentially life‐saving device."

About the VELscope® Vx Enhanced Oral Assessment System

The distinctive blue‐spectrum light of the VELscope® Vx hand‐held device causes the soft tissues of the mouth to naturally fluoresce. Healthy tissues fluoresce in distinct patterns that are visibly disrupted by trauma or disease, such as neoplastic lesions, chemical irritation, side‐effects from medication, thermal damage, fungal, viral or bacterial infections. Use of the VELscope® Vx allows a wide variety of oral abnormalities to be discovered, often before they're visible to the unassisted eye. It is also the only tissue fluorescence device with photo/video documentation capabilities through the viewing mechanism, a key function for referrals and patient records.

About Burkhart Dental Supply

Since 1888, the people of Burkhart have helped dentists achieve personal and professional success through the provision of equipment, repairs, supplies, and consulting. Through integrity, personal service and a commitment to its client's best interest, Burkhart has built a strong distribution network serving more than 5,000 dental practitioners. For more details, visit www.burkhartdental.com.

About LED Medical Diagnostics Inc.

Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc. is a leading developer of LED‐based visualization technologies for the medical industry. The Company is currently listed on the Toronto Stock Exchange (TSX‐V) under the symbol "LMD", the OTCQX under the symbol "LEDIF", as well as the Frankfurt Stock Exchange under the symbol "LME". For more information, visit www.ledmd.com.

Through its wholly‐owned subsidiary, LED Dental Inc., the company manufactures the VELscope® Vx Enhanced Oral Assessment System, the first system in the world to apply tissue fluorescence visualization technology to the oral cavity. VELscope® Vx devices are now used to conduct more screenings for oral cancer and other oral diseases than any other adjunctive device. To date, there have been more than 12,000 VELscope® Vx systems sold globally and they have been used to perform more than 25 million exams. For more information, call 604.434.4614 or visit www.leddental.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

  • LED Medical Diagnostics Inc.
    Mark Komonoski, Investor Relations
    (403) 255-8483 or Toll-Free: (877) 255-8483
    Cell: (403) 470-8384
    mark.komonoski@ledmd.com
    Skype: mkomonoski